These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1748053)

  • 61. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetes; 1993 May; 42(5):715-9. PubMed ID: 8482428
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Audit of antihypertensive treatment in patients with renal failure.
    Schwenger V; Ritz E
    Nephrol Dial Transplant; 1998 Dec; 13(12):3091-5. PubMed ID: 9870471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
    Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
    Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.
    Fagerudd JA; Tarnow L; Jacobsen P; Stenman S; Nielsen FS; Pettersson-Fernholm KJ; Grönhagen-Riska C; Parving HH; Groop PH
    Diabetes; 1998 Mar; 47(3):439-44. PubMed ID: 9519751
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Can we further slow down the progression to end-stage renal disease in diabetic hypertensive patients?
    Bretzel RG
    J Hypertens Suppl; 1997 Mar; 15(2):S83-8. PubMed ID: 9218204
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy.
    Csiky B; Kovács T; Wágner L; Vass T; Nagy J
    Nephrol Dial Transplant; 1999 Jan; 14(1):86-90. PubMed ID: 10052483
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
    Baba T; Ishizaki T
    Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time as a risk factor in diabetic nephropathy.
    Nyberg G; Larsson O; Attman PO; Granérus G; Nordén G
    Diabetes Care; 1985; 8(6):590-3. PubMed ID: 4075945
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk markers of future microalbuminuria and hypertension based on clinical and morphological parameters in young type 1 diabetes patients.
    Perrin NE; Torbjörnsdotter T; Jaremko GA; Berg UB
    Pediatr Diabetes; 2010 Aug; 11(5):305-13. PubMed ID: 19761528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meeting report of the International Society of Hypertension Conference on Hypertension and Diabetes.
    Johnston CI; Cooper ME; Nicholls GM
    J Hypertens; 1992 Apr; 10(4):393-7. PubMed ID: 1316406
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidemiology of hypertension in diabetic patients and implications for treatment.
    Fuller JH; Stevens LK
    Diabetes Care; 1991 Nov; 14 Suppl 4():8-12. PubMed ID: 1748058
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults.
    Moore WV; Donaldson DL; Chonko AM; Ideus P; Wiegmann TB
    Diabetes; 1992 Sep; 41(9):1035-41. PubMed ID: 1499855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The quantitative relationship between treated blood pressure and progression of diabetic renal disease.
    Dillon JJ
    Am J Kidney Dis; 1993 Dec; 22(6):798-802. PubMed ID: 8250025
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence of hypertension in IDDM patients in the northern Grand Canary Island, according to the WHO/ISH and JNC-V/ADA criteria.
    de Pablos-Velasco PL; Martínez-Martín FJ; Aguilar JA
    Diabetes Res Clin Pract; 1997 Dec; 38(3):191-7. PubMed ID: 9483386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypertension in individuals with insulin-dependent diabetes mellitus.
    Anderson J; Rocchini AP
    Pediatr Clin North Am; 1993 Feb; 40(1):93-104. PubMed ID: 8417412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy.
    Sawicki PT; Didjurgeit U; Mühlhauser I; Heinemann L; Berger M
    J Diabet Complications; 1990; 4(4):179-83. PubMed ID: 2151231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical interventions in diabetic renal disease.
    Leese GP; Vora JP
    Curr Opin Nephrol Hypertens; 1995 Mar; 4(2):139-45. PubMed ID: 7600044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus.
    Wiegmann TB; Herron KG; Chonko AM; MacDougall ML; Moore WV
    Diabetes; 1990 Dec; 39(12):1556-60. PubMed ID: 2245880
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Venous compliance and the venodilatory effect of nitroglycerin in insulin-dependent diabetic patients with and without (incipient) nephropathy.
    Schaper NC; Houben AJ; Schoon Y; Kooman JP; Huvers FC; Nieuwenhuijzen Kruseman AC
    Eur J Clin Invest; 1994 Jun; 24(6):382-7. PubMed ID: 7957490
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blood pressure changes in diabetes in urban Tanzania.
    Mugusi F; Ramaiya KL; Chale S; Swai AB; McLarty DG; Alberti KG
    Acta Diabetol; 1995 Mar; 32(1):28-31. PubMed ID: 7612914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.